PMC:7696151 / 10848-11118 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7696151","sourcedb":"PMC","sourceid":"7696151","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7696151","text":"of HCQ was also compared with that of ZDV, a nucleoside reverse transcriptase inhibitor, in a randomized, placebo-controlled clinical trial conducted on 72 HIV-l-infected asymptomatic patients. All subjects were treated for 16 weeks with 800 mg/day HCQ (n = 35) or 500 m","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"303","span":{"begin":184,"end":192},"obj":"Species"},{"id":"322","span":{"begin":3,"end":6},"obj":"Chemical"},{"id":"323","span":{"begin":38,"end":41},"obj":"Chemical"},{"id":"324","span":{"begin":249,"end":252},"obj":"Chemical"},{"id":"337","span":{"begin":156,"end":170},"obj":"Disease"}],"attributes":[{"id":"A303","pred":"tao:has_database_id","subj":"303","obj":"Tax:9606"},{"id":"A322","pred":"tao:has_database_id","subj":"322","obj":"MESH:D006886"},{"id":"A323","pred":"tao:has_database_id","subj":"323","obj":"MESH:D015215"},{"id":"A324","pred":"tao:has_database_id","subj":"324","obj":"MESH:D006886"},{"id":"A337","pred":"tao:has_database_id","subj":"337","obj":"MESH:D015658"},{"subj":"303","pred":"source","obj":"LitCovid-PubTator"},{"subj":"322","pred":"source","obj":"LitCovid-PubTator"},{"subj":"323","pred":"source","obj":"LitCovid-PubTator"},{"subj":"324","pred":"source","obj":"LitCovid-PubTator"},{"subj":"337","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ceec93","default":true}]}]}}